Evaluation of Imatinib adherence in chronic myeloid leukemia patients in Babylon Province, Iraq
Background: Chronic myeloid leukemia is a clonal myeloproliferative neoplasm that results in proliferation, mainly of granulocytic components. Resulting from t(9;22) with fusion oncogen BCR-ABL1 which has uninhibited tyrosine kinase activity. The introduction of tyrosine kinase inhibitors, such as I...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Medical Journal of Babylon |
Subjects: | |
Online Access: | http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2023;volume=20;issue=2;spage=388;epage=392;aulast=Gatea |